Skip to main content

Michael Freeman

Stock Analyst at Raymond James

Total Price Targets
3
Stocks Covered
3
Sectors
Healthcare
Most Recent
Feb 2, 2026

Notable Calls (Last 12 Months)

Most Bullish

  • WVE+93.6%
    Wave Life Sciences Ltd.
    $26.00 targetFeb 2, 2026
  • DYN+71.1%
    Dyne Therapeutics, Inc.
    $40.00 targetDec 8, 2025

Most Bearish

  • DYN+71.1%
    Dyne Therapeutics, Inc.
    $40.00 targetDec 8, 2025
  • WVE+93.6%
    Wave Life Sciences Ltd.
    $26.00 targetFeb 2, 2026

Stocks Covered by Michael Freeman

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
WVEWave Life Sciences Ltd.$26.00$7.32+255.4%1Feb 2, 2026
DYNDyne Therapeutics, Inc.$40.00$17.50+128.6%1Dec 8, 2025
BHCBausch Health Companies Inc.$8.00$5.67+41.1%1Jul 10, 2024

Recent Activity

  • Feb 2, 2026— Set$26.00price target onWVE(Wave Life Sciences Ltd.)
  • Dec 8, 2025— Set$40.00price target onDYN(Dyne Therapeutics, Inc.)
  • Jul 10, 2024— Set$8.00price target onBHC(Bausch Health Companies Inc.)

Frequently Asked Questions

Who is Michael Freeman?

Michael Freeman is a stock analyst at Raymond James covering 3 stocks primarily in Healthcare. They have issued 3 price targets since Jul 10, 2024.

What stocks does Michael Freeman cover?

Michael Freeman currently covers 3 stocks, including WVE, DYN, BHC.

What is Michael Freeman's latest price target?

Michael Freeman's most recent price target was $26.00 on WVE (Wave Life Sciences Ltd.), set on Feb 2, 2026.

What is Michael Freeman's highest price target?

Michael Freeman's highest issued price target is $40.00 on DYN, set on Dec 8, 2025.

More Analysts at Raymond James

Strong Buy
Raymond James
Targets41
Stocks41
Patrick Tyler Brown
Raymond James
Targets40
Stocks17
Simon Leopold
Raymond James
Targets31
Stocks13
Brian Gesuale
Raymond James
Targets30
Stocks22

Coverage based on publicly published price targets. Not investment advice.